Category: Uncategorized

We are pleased to announce our latest publication on RetmarkerAMD® validation, published in the Eye newspaper, a Springer Nature group and official publication of the UK College of Ophthalmologists.

By conducting a carefully planned multicentre, cross-sectional study, we were able to demonstrate that RetmarkerAMD® is a reliable and consistent semiautomated classification tool for Age-related Macular Degeneration, which may be used both in clinical studies and in clinical trials.

RetmarkerAMD® is a software developed by the Retmaker company in partnership with AIBILI that facilitates the marking and counting of Age-related Macular Degeneration (AMD) lesions. It was initially developed for the epidemiological Coimbra Eye Study and has since been used in several other studies.

Journal Reference:

https://www.nature.com/articles/s41433-019-0624-7

AIBILI was represented by Diogo Mendes at the 19^th Annual Meeting of the ISoP International Society of Pharmacovigilance, in Bogotá (Colombia, October 26 to 29).

AIBILI organized in the EVICR.net annual Members Meeting, on October 24 and 25, at Infarmed (Lisbon) that was attended by about 100 participants who had the opportunity to update on the activities in the different subspecialty areas to network and discuss new clinical study ideas and EU applications.

Members of CHAD team were present on the 8^th Pharmacovigilance Seminar of Spanish Pharmacovigilance System for Medicinal Products for Human Use, took place in Tordesillas, Spain, on October 23-25. This was the first time the meeting was held in a joint organization with the Portuguese Pharmacovigilance System.

Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 6, Nº 2 – 2º Trimestre . Consulte: Farmacovigilância – Atualizações de segurança de medicamentos Vol 6N 2

AIBILI was present at TECH@PORTUGAL, on the 4th of July at Alfândega do Porto, an event that presented the best Portuguese innovation and technology.

We would like to thank to our partner Retmarker to the support, and to ANI – Agência Nacional de Inovação for the invitation!

 

Partilhamos agora o testemunho do Prof. Cunha-Vaz sobre o nosso Demonstrador Tecnológico, realizado ontem (6 de Junho).
Desde já agradecemos à ANI – Agência Nacional de Inovação e a todos os presentes pela oportunidade que nos deram de vos apresentar as nossas unidades e projetos.

O Demonstrador Tecnológico é uma iniciativa promovida pela ANI no âmbito do SIAC – Iniciativa de Transferência de Conhecimento, cofinanciada pelo COMPETE 2020, através do Portugal 2020 e do Fundo Europeu de Desenvolvimento Regional.

Decorreu no dia 06/06/2019 o Demonstrador Tecnológico AIBILI. Este evento foi organizado em parceria pela Agência Nacional de Inovação (ANI) e a AIBILI, e contará com a presença do Sr. Prof. Eduardo Maldonado, Presidente do Conselho de Administração da ANI e do Sr. Dr. João Correia Neves, Secretário de Estado da Economia. Aceda aqui ao Programa e formulário de inscrição.

AIBILI participated in the BIOMEET 2019 to celebrate 20 years of P-BIO. The event took place in Carcavelos on 07/05/2019. Please see here the programme. Prof. Batel Marques and Dr. Daniel Fernandes will make two presentations. Don’t miss this opportunity!

Farmacovigilância: Atualizações de segurança de medicamentos – Vol. 6, Nº 1
Pharmacovigilance: Updates on drug safety is a quarterly publication issued by the Pharmacovigilance Unit of Coimbra (UFC) delivering to patients and healthcare professionals information on the risks and safe use of medicines. Farmacovigilância: Atualizações de segurança de medicamentos é uma publicação trimestral editada pela Unidade de Farmacovigilância de Coimbra (UFC) com o objetivo de disponibilizar informação de segurança dos medicamentos aos utentes e profissionais de saúde.